Arax Advisory Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.1K | Buy |
137
+22
| +19% | +$5.31K | ﹤0.01% | 1432 |
|
|
2025
Q1 | $28K | Buy |
115
+92
| +400% | +$22.4K | ﹤0.01% | 1162 |
|
|
2024
Q4 | $7.56K | Buy |
+23
| New | +$7.56K | ﹤0.01% | 1587 |
|
|
2024
Q2 | – | Sell |
-3
| Closed | -$1.04K | – | 2547 |
|
|
2024
Q1 | $1.04K | Buy |
+3
| New | +$1.04K | ﹤0.01% | 1148 |
|
|
2023
Q2 | – | Sell |
-7
| Closed | -$3.35K | – | 1273 |
|
|
2023
Q1 | $3.35K | Hold |
7
| – | – | ﹤0.01% | 927 |
|
|
2022
Q4 | $2.94K | Buy |
+7
| New | +$2.94K | ﹤0.01% | 901 |
|
|
2021
Q3 | – | Sell |
-10
| Closed | -$6K | – | 996 |
|
|
2021
Q2 | $6K | Buy |
+10
| New | +$6K | ﹤0.01% | 731 |
|